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Abstract. Data showed that 235 million people suffer from asthma with death rate more 
than 80% in developing countries. The pharmacist's role in managing asthma is to 
overcome drug-related problems that arise, provide information and counseling, motivate 
patients to adhere the treatment and assist in Medication Record. This study aims to 
determine the effect of the application of pharmaceutical care on drug therapy problems, 
adherence, therapeutic outcomes and quality of life in asthma patients. Data were carried 
out based on observation, interviews, and through filling questionnaires by asthma patients 
who redeem prescriptions at Apotek Dety Jl. Kapten Muslim No. 45A Medan from July to 
November 2020 who met the inclusion criteria. Number of DRP incidents obtained 
according to PCNE V9.0. Data were analyzed statistically used the Friedman and Wilxocon 
test. The result showed that There was a significant decrease in the problem group after the 
intervention was carried out by 93.3%. Based on the results of the study it can be concluded 
that the application of pharmaceutical care in asthma patients has a significant effect on 
reduced drug therapy. 
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Abstrak. Data menunjukkan 235 juta orang menderita asma dengan angka kematian lebih 
dari 80% terjadi di negara-negara berkembang. Peran apoteker dalam penanganan 
penyakit asma adalah mengatasi masalah terkait obat yang mungkin timbul, memberikan 
informasi dan konseling, memotivasi pasien untuk patuh dalam pengobatan serta 
membantu dalam pencatatan medication record. Penelitian ini bertujuan untuk mengetahui 
pengaruh penerapan asuhan kefarmasian terhadap masalah terapi obat, kepatuhan, 
outcome klinis dan kualitas hidup pada pasien asma. Pengumpulan data dilakukan 
berdasarkan observasi, wawancara, dan melalui pengisian kuesioner oleh pasien asma 
yang menebus resep di Apotek Dety Jl. Kapten Muslim No. 45A Medan periode Juli-
November 2020 dan memenuhi kriteria inklusi. Data berupa jumlah kejadian DRP yang 
diperoleh menurut PCNE V9,0. Data yang diperoleh dianalisis secara statistik 
menggunakan uji friedman dan wilxocon. Hasil menunjukkan penerapan asuhan 
kefarmasian dapat digunakan untuk mengidentifikasi masalah obat pasien asma di apotek 
yang dibuktikan melalui Uji Wilcoxon Signed Ranks dengan nilai p<0,05, dapat 
meningkatkan kepatuhan yang terbukti pada penurunan kepatuhan pasien kategori rendah 
sebelum intervensi sebesar 61,1% dan mencapai 0% setelah intervensi dan dapat 
meningkatkan outcome pasien asma di apotek yang dibuktikan dari peningkatan nilai APE 
sebelum dan sesudah intervensi sebesar 16,36% dan dapat meningkatkan kualitas hidup 
sebelum intervensi kategori sedang (88,9%) menjadi kategori baik (83,3%) setelah 
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pada pasien asma memiliki pengaruh yang signifikan terhadap penurunan masalah terapi 
obat, peningkatan kepatuhan, outcome klinis dan kualitas hidup pasien.  
Kata Kunci: asma, masalah obat, asuhan kefarmasian 
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1. Introduction 
Asthma is a chronic respiratory disease characterized by increased reactivity to various stimuli 
and airway obstruction which can return spontaneously or with appropriate treatment. 
According to WHO in 2019, around 235 million people suffer from asthma with a death rate of 
more than 80% occurring in developing countries. Based on data from the Centers for Disease 
Control and Prevention in 2018 in the United States, the prevalence of asthma by age group is 
7.7% in adults and 7.5% in children, based on gender, 6.2% for men and 9.1% female, and 
based on race 7.6% white race and 10.6% black race [1]. 
 
Basic Indonesian Health Research in 2018 found the prevalence rate of asthma at all ages in 
Indonesia was 2.4%. Meanwhile, the incidence of asthma in North Sumatra is 1.0%. The 
incidence of asthma in women tends to be higher than men (Ministry of Health, 2018). 
Pharmacy is a pharmacy service facility where pharmacists are practicing pharmacy. The 
pharmacy as a pharmaceutical service facility is directly responsible to patients in relation to the 
pharmaceutical preparations they obtain and is an important concern because it is oriented 
towards improving the patient's quality of life. To improve the quality of pharmaceutical 
services at pharmacies, we need a standard that can be used as a reference in pharmaceutical 
services at pharmacies. This pharmaceutical service standard has been regulated in the Minister 
of Health's Regulation through Pharmaceutical Service Standards at Pharmacy Number 73 of 
2016 [2]. 
Pharmaceutical Care is defined as the pharmacist's direct responsibility in providing drugs to 
improve the quality of life of patients, which is a philosophy of practice for pharmacists as well 
as a standard for providing pharmaceutical services to patients. The philosophy of practice in 
this pharmaceutical service system leads to patient-oriented pharmaceutical care. Thus, 
pharmacists as professionals are required to increase knowledge, skills, and behavior changes so 
that they can interact directly with patients [2]. The pharmacist's role in managing asthma is to 
overcome drug-related problems that may arise, provide information and counseling, motivate 
patients to adhere to treatment and assist in recording for medication (Medication Record). 
Pharmacists in this case can help manage asthma by directing patients suspected of having 
asthma to check themselves, motivating patients to comply with treatment, providing 
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About 45-75% of injuries that arise due to drug therapy problems are preventable and 
Pharmacists are the most appropriate health professionals to identify and treat drug-related 
problems. This is a great opportunity in an effort to improve the quality of the health system 
considering that the number of incidents can be reduced [4]. 
Based on the description above, the researcher is interested in conducting research related to the 
implementation of pharmaceutical care in asthma patients at one of the pharmacies in Medan. 
2. Material and Methods 
2.1 Study Design 
The study was conducted using a comparative experimental method with a prospective cohort 
study design in asthma patients who bought their prescriptions at the Dety Pharmacy Jl. Captain 
Muslim No. 45A Medan in the period July-November 2020 and met the study inclusion criteria. 
Data collection was carried out based on observation, interviews, and through filling out 
questionnaires by patients. Data in the form of the number of DRP events obtained according to 
PCNE V9.0, the data obtained were analyzed statistically using the Friedmann and Wilxocon 
test and presented in tabular form. 
 2.2 Sample 
Experimental and comparative research requires a sample of 15-30 respondents (Borg et al., 
2007) Gay et al. (2009) also stated that experimental and comparative research required a 
sample of 30 respondents [6,7] 
Inclusion criteria  
patients who have been diagnosed for more than 2 months who redeem the prescription at the 
Dety Pharmacy Captain Muslim street No. 45A Medan, Patients aged 13 years and over, 
Asthma patients with persistent asthma category, asthma patients with or without comorbidities, 
and patients willing to participate in the study. 
2.3 Data analysis 
The data obtained in this study were statistically analyzed using the Friedman and Wilxocon 
method. 
3. Results and Discussions 
3.1 Patients characteristic 
The demographic data of the patients studied included gender, patient age, education and 
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Table 1. Patient Characteristics 
                Patient Characteristics 
 
Total 
n (36) Percentage 
(%) 
 Gender 
 Male 15 41.7 




26-35 5 13.9 
36-45 3 8.3 
46-55 6 16.7 
56-65 16 44.4 
>65 6 16.7 
 
Education 
Bachelor 20 55.6 
Senior high school 14 38.9 
Junior high school 2 5.6 
 
Occupation 
  Housewife 6 16.7 
Government employees 7 19.4 
Enterprenuer 13 36.1 
Etc 10 27.8 
 
Data from the demographic study of patients based on age in Table 1 shows that the most 
asthma sufferers were aged 56-65 as many as 16 people (44.4%). This result is in accordance 
with Andayani's research (2014) which reported that 83% of asthma patients in Indonesia are 
18-60 years old and 17% are> 60 years old. Pangestuti, et al. (2015) stated that the decrease in 
respiratory function in terms of the value of the Forced Expiratory Volume in one second w 
(FEV₁) has a significant relationship with age level. From the age of 35 to 40 years, the mean 
reduction in FEV1 was 25–30 ml / year and those over 70 years of age had a decrease of 60 ml / 
year. 
Drug related problems are an event or situation that involves drugs and can actually or 
potentially interfere with the desired results (PCNE, 2019). Based on the results of statistical 
analysis using the Wilcoxon test, the number of DRPs incidents showed a significant difference 
of p <0.05 (p = 0.00) in the pretest and posttest, which means that there was an effect of the 
application of pharmaceutical care on Drug Related Problems (DRPs) before and after the 
intervention. DRPs in this study are the cumulative total group of problems (problems / P) with 
groups of causes (causes / C). Drug related problems (DRPs) have the potential to contribute to 
morbidity and mortality in asthma [8]. The average DRPs problems per patient before and after 
the intervention can be seen in table 2 below 
Table 2. Average DRP problems per patient before and after the intervention 
Average DRP problems per patient Uji Wilcoxon 
Asymp.Sig 
Pretest Post test 
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Basically, a problem is defined as an unexpected or unforeseen event or circumstance that is, or 
may have gone wrong, with medication. There are 3 main domains in the problem section, 
namely: 1) The clinical effect of the drug is not as expected or absent, 2) The patient has ADR 
at normal doses or from a toxic reaction, 3) It seems that there is nothing wrong in the treatment, 
but there are other problems that related to the drugs used. Based on the results of this study, for 
the problem group (problems / P), the average P statistical analysis results before the 
intervention (pre-test) was 0.42 ± 0.500, while after the intervention (post test) it decreased to 
0.03 ± 0.167. In the P average normality test before and after the intervention was statistically 
tested using the Kolmogorov-Smirnov test with a p value <0.05, which means that the data was 
not normally distributed, the Wilcoxon Signed Ranks Test was performed with a p value <0.05 
(p = 0.00) so it can be concluded that there is a significant difference in the P average before 
and after the intervention. The significant difference can be seen from the decrease in the 
percentage of problem groups (Problems / P) after the intervention was carried out by 93.3%. 
Table 3. Causes of DRPs(P) Before and After Intervention 
Code Cause of DRPs Total of causes (%) Total 
decrease 
(%) Pretest Post Test 
P   DRPs Problem 15 (100%) 1 (100%) 93.3 
P.1 Effectivity 13 (86.7%) 1 (100%) 92.3 
P 1.2 Drug effect is not optimum 13 (86.7%) 1 (100%) 93.3 
P.3   Etc 2 (13.3%) 0 (0%) 100 
P.3.3 Unclear causes 2 (13.3%) 0 (0%) 100 
 
The problem group that caused the highest DRP was the suboptimal drug effect (86.7%). This is 
in accordance with Zhu's (2019) study where DRP was identified, especially at the patient level, 
drug selection, and drug use process, and this accounted for 73.5% of the cause so that the effect 
was not optimal. This shows that the patient's drug use, doctor's prescription, and drug 
administration can all affect the effect of the drug, so medication counseling by pharmacists is 
needed. After interviewing clinical pharmacists with patients, it was found that many patients 
had insufficient knowledge of drugs and poor inhaler use skills leading to poor control of 
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Figure 1. Causes of the incidence of DRPs before and after the intervention 
Based on the results of the study, the problem group that caused the highest DRP was C.7 
related to patients at 63.63% consisting of C.7.1 (22.7%), C.7.2 (4.5%), C.7.7 (27 , 7%) and 
C.7.9 (9.09%), the cause of DRP can be related to the patient and the symptoms of the disease, 
based on PCNE (2019) patient-related treatment problems can occur due to several things, 
namely patients using / taking less drugs than prescribed. or not taking medication at all, the 
patient is using / consuming more drugs than prescribed, the patient is abusing the drug 
(unregulated overuse), the patient is taking unnecessary drugs, the patient is taking food that 
interacts with the drug, the patient is storing drugs inappropriately , the time interval or dose is 
not correct, the patient gives / uses the drug in the wrong way and the patient cannot use the 
drug directly. Inadequate drug dosage means that the drug does not reach the MEC (minimum 
effective concentration) so that it does not have an effect, this is because the dose is too low for 
the desired effect, the drug use interval is too long, interactions occur that cause reduced 
bioavailability, and the duration of the drug is too short [10]. The identification, prevention and 
management of DRP is at the core of pharmaceutical care. Support from policy makers, 
ministries of health, universities, health care professionals, and researchers is needed and 
strongly recommended to improve the pharmaceutical practice of identifying, preventing and 
managing DRP [11]. 
5. Conclusion 
Pharmaceutical care can be used to identify drug problems for asthma patients in pharmacies, 
there is a significant difference in the average P before and after the intervention (p <0.05) with 
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